Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion

Tubercle and Lung Disease

Volumn 79, Issue 4, 1999, Pages 191-198

  Yu, K ^a   Mitchell, C ^a   Xing, Y ^a   Magliozzo, R S ^b   Bloom, B R ^a   Chan, J ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITROGEN DIOXIDE; NITROGEN OXIDE; PEROXYNITRITE;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG SENSITIVITY; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032830066     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.1998.0203     Document Type: Article

References (41)

1. Chanock S J, el Benna J, Smith R M, Babior B M. The respiratory burst oxidase. J Biol Chem. 269:1994;24519-24522.
2. Iyer G Y N, Islam M F, Quastel J H. Biochemical aspects of phagocytosis. Nature (London). 192:1961;535-541.
3. Nathan C F. Mechanisms of macrophage antimicrobial activity. Trans R Soc Trop Med Hyg. 77:1983;620-630.
4. Wientjes F B, Segal A W. NADPH oxidase and the respiratory burst. Seminars in Cell Biol. 6:1995;357-365.
5. Fang F C. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest. 99:1997;2818-2825.
6. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 15:1997;323-350.
7. Nathan C. Inducible nitric oxide synthase: What difference does it make. J Clin Invest. 100:1997;2417-2423.
8. Ding A H, Nathan C F, Stueher D J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol. 141:1988;2407-2412.
9. Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cellu Immunol. 132:1991;150-157.
10. Chan J, Xing Y, Magliozzo R S, Bloom B R. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 175:1992;1111-1122.
11. Flynn J L, Chan J, Triebold K J, Dalton D K, Stewart T A, Bloom B R. An essential role for IFN-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med. 178:1993;2249-2254.
12. Chan J, Tanaka K, Carroll D, Flynn J, Bloom B R. Effects of nitric oxide synthase inhibitors on murine infection with M. tuberculosis. Infect Immun. 63:1994;736-740.
13. Flynn J L, Goldstein M M, Chan J. Tumor necrosis factor is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity. 2:1995;561-572.
14. MacMicking J, North R J, LaCourse R, Mudgett J S, Shah S K, Nathan C F. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA. 84:1997;5243-5248.
15. Flynn J, Scanga C A, Tanaka K, Chan J. Reactivation of latent murine tuberculosis by inhibition of inducible nitric oxide synthase. J Immunol. 160:1998;1796-1803.
16. Zhu L, Gunn C, Beckman J S. Bactericidal activity of peroxynitrite. Arch Biochem Biophys. 298:1992;452-457.
17. Brunelli L, Crow J P, Beckman J S. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch Biochem Biophys. 316:1995;327-334.
18. Friedman C R, Quinn G C, Kreiswirth B N. Widespread dissemination of a drug-susceptible strain of Mycobacterium tuberculosis. J Infect Dis. 176:1997;478-484.
19. Riska P, Jacobs W R Jr, Bloom B R, McKitrick J, Chan J. Specific identification of Mycobacterium tuberculosis by the luciferase reporter mycobacteriophage: the use of β-nitro-α-acetylamino-β-hydroxy-propiophenone. J Clinical Microbiol. 35:1997;3225-3231.
20. Sambrook, J, Fritsch, E, F, Maniatis, T, Molecular Cloning 1989; Second Editions, Cold Spring Harbor Laboratory Press.
21. Reed J W, Ho H H, Jolly W L. Chemical syntheses with a quenched flow reactor. Hydroxytrihydroborate and peroxynitrite. J Amer Chem Soc. 96:1973;1248-1249.
22. Beckman J S, Beckman T W, Chen J, Marshall P A, Freeman B A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 87:1990;1620-1624.
23. Beckman J S, Chen J, Ischiropoulos H, Crow J P. Oxidative chemistry of peroxynitrite. Methods in Enzymol. 233:1994;229-240.
24. Ignarro L J, Byrns R E, Buga G M, Wood K S. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res. 61:1987;866-879.
25. Stuehr D J, Nathan C F. Nitric oxide: A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 169:1989;1543-1555.
26. Beckman J S, Koppenol W H. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 271:1996;C1424-1437.
27. Ischiropouls H, Zhu L, Beckman J S. Peroxynitrite formation from macrophage-derived nitric oxide. Arch Biochem Biophys. 298:1992;446-451.
28. Haber F, Weiss J. The catalytic decomposition of hydrogen peroxide by iron salts. Proc R Soc London Ser. A147:1934;332-351.
29. Shank J L, Silliker J H, Harper R H. The effect of nitric oxide on bacteria. Appl Microbiol. 10:1962;185-189.
30. Cotton F A, Wilkinson G. Advanced Inorganic Chemistry. A Comprehensive Text. 1980;John Wiley and Sons, Inc. p. 423-428.
31. Nicholson S, Monecini-Almeida M da G, Lapa e Silva J R. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med. 183:1996;2293-2302.
32. Stamler J S, Singel D J, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science. 258:1992;1898-1902.
33. Stamler J S. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell. 78:1994;931-936.
34. Huie R E, Padmaja S. The reaction rate of nitric oxide with superoxide. Free Radical Res Commun. 18:1993;195-199.
35. Denicola A, Rubbo H, Rodriguez D, Radi R. Peroxynitrite-mediated cytotoxicity to Trypanosoma cruzi. Arch Biochem Biophys. 304:1993;279-286.
36. Rubbo H, Denicola A, Radi R. Peroxynitrite inactivates thiol-containing enzymes of Trypanosoma cruzi energetic metabolism and inhibits cell respiration. Arch Biochem Biophys. 308:1994;96-102.
37. Vasquez-Torres A, Jones-Carson J, Balish E. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages. Infect Immun. 64:1996;3127-3133.
38. Assreuy J, Cunha F Q, Epperlein M, Noronha-Dutra A, O'Donnell C A, Liew F Y, Moncada S. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur J Immunol. 24:1994;672-676.
39. O'Brian L, Carmichael J, Lowrie D B, Andrew P W. Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect Immun. 62:1994;5187-5190.
40. Ehrt S, Shiloh M U, Ruan J, Choi M, Gunzburg S, Nathan C, Xie Q-W, Riley L W. A novel antioxidant gene from Mycobacterium tuberculosis. J Exp Med. 186:1997;1885-1896.
41. Chen L, Xie Q-W, Nathan C. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol Cell. 1:1998;795-805.